177
Views
3
CrossRef citations to date
0
Altmetric
Perspective

Assessing the pricing and benefits of oncology products: an update

ORCID Icon
Pages 335-342 | Received 26 Jan 2021, Accepted 04 May 2021, Published online: 25 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Panagiotis Petrou, Olga Pitsillidou & M. J. Postma. (2022) The notion of Surrogacy in Health Technology Assessment: an insight in the processes of Germany, UK and France. Journal of Medical Economics 25:1, pages 321-323.
Read now

Articles from other publishers (2)

I. Wolf, B. Waissengrin, A. Zer, R. Bernstein-Molho, K. Rouvinov, J.E. Cohen, N. I Cherny & G. Bar-Sela. (2022) Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement Process. ESMO Open 7:1, pages 100379.
Crossref
Stavroula Koilakou & Panagiotis Petrou. (2021) Economic Evaluation of Monoclonal Antibodies in Metastatic Colorectal Cancer: A Systematic Review. Molecular Diagnosis & Therapy 25:6, pages 715-734.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.